Literature DB >> 10570727

Headache in schizophrenic patients: a controlled study.

A Kuritzky1, D Mazeh, A Levi.   

Abstract

Various studies have indicated that chronic schizophrenic patients share a lower rate of headaches than the normal population. A questionnaire concerning the symptomatology of headache was administered to 108 schizophrenic patients in the chronic stage and to 100 normal subjects. The questions dealt with type, location, frequency, severity, and duration of headache, as well as with its accompanying phenomena. Both groups shared a high distribution of headache reports, and generally no significant differences were observed in the various parameters. It was found that schizophrenic patients tend to refrain from complaining about their headache, although they are capable of its precise description. No correlation was found between the type of headache and type of schizophrenia.

Entities:  

Mesh:

Year:  1999        PMID: 10570727     DOI: 10.1046/j.1468-2982.1999.019008725.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  5 in total

1.  [Extraordinary cause of a self-induced focal epilepsy].

Authors:  G Winkler; N Aktas; W Kuhn
Journal:  Nervenarzt       Date:  2005-12       Impact factor: 1.214

Review 2.  Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care.

Authors:  Marian J T Oud; Betty Meyboom-de Jong
Journal:  BMC Fam Pract       Date:  2009-05-09       Impact factor: 2.497

3.  Pain perception in schizophrenia: influence of neuropeptides, cognitive disorders, and negative symptoms.

Authors:  Małgorzata Urban-Kowalczyk; Justyna Pigońska; Janusz Śmigielski
Journal:  Neuropsychiatr Dis Treat       Date:  2015-08-06       Impact factor: 2.570

4.  Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illness.

Authors:  Ashli Owen-Smith; Christine Stewart; Musu M Sesay; Sheryl M Strasser; Bobbi Jo Yarborough; Brian Ahmedani; Lisa R Miller-Matero; Stephen C Waring; Irina V Haller; Beth E Waitzfelder; Stacy A Sterling; Cynthia I Campbell; Rulin C Hechter; John E Zeber; Laurel A Copeland; Jeffrey F Scherrer; Rebecca Rossom; Greg Simon
Journal:  BMC Psychiatry       Date:  2020-01-31       Impact factor: 3.630

5.  Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.

Authors:  Sylvie Tordjman; George M Anderson; Michel Botbol; Sylvie Brailly-Tabard; Fernando Perez-Diaz; Rozenn Graignic; Michèle Carlier; Gérard Schmit; Anne-Catherine Rolland; Olivier Bonnot; Séverine Trabado; Pierre Roubertoux; Guillaume Bronsard
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.